Literature DB >> 16862180

Akt regulates nuclear/cytoplasmic localization of tuberin.

M Rosner1, A Freilinger, M Hengstschläger.   

Abstract

The autosomal dominantly inherited disease tuberous sclerosis (TSC) affects approximately 1 in 6000 individuals and is characterized by the development of tumors, named hamartomas, in different organs. TSC1, encoding hamartin, and TSC2, encoding tuberin are tumor suppressor genes responsible for TSC. Hamartin and tuberin form a complex, of which tuberin is assumed to be the functional component. The TSC proteins have been implicated in the control of cell cycle by activating the cyclin-dependent kinase inhibitor p27 and in cell size regulation by inhibiting the mammalian target of rapamycin (mTOR)/p70S6K cascade. Phosphorylation of S939 and T1462 by Akt downregulates tuberin's potential to inhibit mTOR/p70S6K. Here, we show that this tuberin phosphorylation by Akt does not affect tuberin-mediated control of p27 protein amounts. This demonstrates that regulating p27 protein amounts and mTOR/p70S6K are separable functions of tuberin. Furthermore, we found that phosphorylation by Akt triggers upregulation of cytoplasmic and downregulation of nuclear tuberin. In cycling cells with high Akt activity, tuberin is predominantly localized to the cytoplasm. In arrested G0 cells with downregulated Akt activity, a significant proportion of tuberin is localized to the nucleus. Upon re-entry into the normal ongoing cell cycle, nuclear localization of tuberin is downregulated parallel to the activation of Akt. Recently, the mTOR/p70S6K cascade has been demonstrated to exist in both the cytoplasm and nucleus. We here also found that tuberin harbors the potential to regulate p70S6K activity in both the cytoplasm and nucleus. This description of functional tuberin in the cytoplasm and the nucleus together with our observation of Akt-controlled and cell cycle-regulated tuberin localization are of particular interest for a further understanding of tuberin's function as a gate keeper of the G0 cell status as well as of Akt's activity to control cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862180     DOI: 10.1038/sj.onc.1209812

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

Review 1.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

2.  Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an american ophthalmological society thesis).

Authors:  Stephen H Tsang; Lawrence Chan; Yi-Ting Tsai; Wen-Hsuan Wu; Chun-Wei Hsu; Jin Yang; Joaquin Tosi; Katherine J Wert; Richard J Davis; Vinit B Mahajan
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 3.  Mammalian TOR signaling to the AGC kinases.

Authors:  Bing Su; Estela Jacinto
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-10       Impact factor: 8.250

4.  Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.

Authors:  Raghavendra Vadla; Devyani Haldar
Journal:  Cell Cycle       Date:  2018-01-08       Impact factor: 4.534

5.  Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes.

Authors:  Catherine Itman; Chris Small; Michael Griswold; Ankur K Nagaraja; Martin M Matzuk; Chester W Brown; David A Jans; Kate L Loveland
Journal:  Dev Dyn       Date:  2009-07       Impact factor: 3.780

6.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

7.  RHEB1 expression in embryonic and postnatal mouse.

Authors:  Qi Tian; James L Smart; Joachim H Clement; Yingming Wang; Alex Derkatch; Harald Schubert; Michael V Danilchik; Daniel L Marks; Lev M Fedorov
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

8.  The mTORC1 signaling repressors REDD1/2 are rapidly induced and activation of p70S6K1 by leucine is defective in skeletal muscle of an immobilized rat hindlimb.

Authors:  Andrew R Kelleher; Scot R Kimball; Michael D Dennis; Rudolf J Schilder; Leonard S Jefferson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-27       Impact factor: 4.310

9.  Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway.

Authors:  Linda M DiBella; Alice Park; Zhaoxia Sun
Journal:  Hum Mol Genet       Date:  2008-11-13       Impact factor: 6.150

10.  Genetics and molecular biology of tuberous sclerosis complex.

Authors:  Valerio Napolioni; Paolo Curatolo
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.